A Trial of SHR-1314 Injection in Adult Patients With Active Non-radiographic Axial Spondyloarthritis

PHASE3RecruitingINTERVENTIONAL

Enrollment

380

Participants

Timeline

Start Date

April 29, 2025

Primary Completion Date

February 29, 2028

Study Completion Date

December 31, 2028

Conditions

Active Non-radiographic Axial Spondyloarthritis

Interventions

DRUG

SHR-1314 Injection

SHR-1314 injection.

DRUG

SHR-1314 Placebo Injection

SHR-1314 placebo injection.

Trial Locations (1)

RECRUITING

Chinese PLA General Hospital, Beijing

All Listed Sponsors

lead

Suzhou Suncadia Biopharmaceuticals Co., Ltd.

INDUSTRY